Effect of clinical outcomes data on intensive care unit utilization by bone marrow transplant patients

Critical Care Medicine
H L PazI Brodsky

Abstract

To determine if a program to educate referring physicians as to the poor outcome of mechanically ventilated bone marrow transplant patients would result in a change in intensive care unit (ICU) utilization. Retrospective chart review. Medical ICU at an urban university hospital. Patients undergoing bone marrow transplantation in the interval before (n = 236) vs. the interval after (n = 144) a physician education program. Two separate educational programs were conducted for oncologists and intensivists to review the findings of an earlier study demonstrating the outcome of bone marrow transplant patients in the ICU. The results demonstrated that this physician education intervention did not result in a change in the utilization of medical ICU resources by these patients. Comparing the time periods before and after the intervention, there were no statistically significant differences in the proportion of patients who were admitted to the medical ICU, the proportion who received mechanical ventilation, or the medical ICU lengths of stay. Similarly, the two groups did not differ regarding the 100-day survival rate of all bone marrow transplant patients studied, all bone marrow transplant patients admitted to the medical ICU, or all...Continue Reading

References

Mar 1, 1992·The American Review of Respiratory Disease·S W Crawford, F B Petersen
Jul 1, 1990·Medical Decision Making : an International Journal of the Society for Medical Decision Making·W A KnausS E Marcus
Jan 1, 1989·Critical Care Medicine·S J DenardoP E Bellamy
May 1, 1989·Archives of Internal Medicine·E H Morreim
Mar 1, 1988·The American Review of Respiratory Disease·S W CrawfordJ G Clark
Oct 1, 1985·Critical Care Medicine·W A KnausJ E Zimmerman
Dec 13, 1984·The New England Journal of Medicine·N G Levinsky
Apr 22, 1983·JAMA : the Journal of the American Medical Association·R W Evans
Jun 12, 1993·Lancet·L S MurrayP Jones
Oct 21, 1993·The New England Journal of Medicine·P J Greco, J M Eisenberg
May 8, 1992·Kennedy Institute of Ethics Journal·R Baker, M Strosberg

❮ Previous
Next ❯

Citations

Mar 26, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G MaschmeyerP Hohenberger
Jun 11, 2005·Chest·Allan Garland
Dec 1, 2009·Critical Care Clinics·Bekele Afessa, Elie Azoulay
Dec 1, 2009·Critical Care Clinics·Márcio SoaresJorge I F Salluh
May 9, 2006·Pediatric Transplantation·Saraswati KacheTheodore B Moore
Mar 6, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Melhem SolhLinda J Burns
Dec 29, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Frédéric PèneJean-Paul Mira
Jul 9, 1999·Critical Care Medicine·T Bojko, D A Notterman
Oct 1, 2008·Critical Care Medicine·Jeremy M KahnDavid A Asch
Nov 5, 2004·Medicine·Élie AzoulayBenoît Schlemmer
Jan 20, 2015·Critical Care Medicine·Gagan KumarUNKNOWN Milwaukee Initiative in Critical Care Outcomes Research Group of Investigators
Aug 7, 2002·Critical Care Medicine·Jack E Zimmerman
Jan 24, 2002·Current Opinion in Critical Care·R A Barnes, N Stallard
Apr 4, 2003·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·F VallotJ P Sculier

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.